-
31.
公开(公告)号:US20050002938A1
公开(公告)日:2005-01-06
申请号:US09784332
申请日:2001-02-16
申请人: Gregory Plowman , James Bischof
发明人: Gregory Plowman , James Bischof
IPC分类号: G01N33/573 , A01N25/00 , A61K31/7088 , A61K38/00 , A61K39/395 , A61K45/00 , A61K47/00 , A61K48/00 , A61P35/00 , C07H21/04 , C07K14/705 , C07K16/40 , C12N1/15 , C12N1/19 , C12N1/20 , C12N1/21 , C12N5/06 , C12N5/10 , C12N9/12 , C12N15/00 , C12N15/09 , C12N15/54 , C12P21/08 , C12Q1/48 , C12Q1/54 , C12Q1/68
CPC分类号: C12N9/1205 , A01K2217/05 , A61K38/00 , C12Q1/485 , G01N2333/9121 , G01N2500/02 , G01N2500/04 , G01N2500/10
摘要: The present invention relates to AUR1 and/or AUR2 polypeptides, nucleic acids encoding such polypeptides, cells, tissues and animals containing such nucleic acids, antibodies to such polypeptides, assays utilizing such polypeptides, and methods relating to all of the foregoing. Methods for treatment, diagnosis, and screening are provided for AUR1 and/or AUR2 related diseases or conditions characterized by an abnormal interaction between a AUR1 and/or AUR2 polypeptide and a AUR1 and/or AUR2 binding partner.
摘要翻译: 本发明涉及AUR1和/或AUR2多肽,编码此类多肽的核酸,含有此类核酸的细胞,组织和动物,此类多肽的抗体,利用此类多肽的测定法以及与上述所有相关的方法。 AUR1和/或AUR2相关疾病或特征为AUR1和/或AUR2多肽与AUR1和/或AUR2结合配偶体之间异常相互作用的病症的治疗,诊断和筛选方法。
-
公开(公告)号:US5972676A
公开(公告)日:1999-10-26
申请号:US974655
申请日:1997-11-19
申请人: Gregory Plowman , Kevin Mossie
发明人: Gregory Plowman , Kevin Mossie
IPC分类号: G01N33/53 , A61K31/00 , A61K31/70 , A61K38/00 , A61K48/00 , A61P35/00 , C07K16/40 , C12N5/10 , C12N9/12 , C12N15/00 , C12N15/02 , C12N15/09 , C12N15/12 , C12N15/54 , C12P21/08 , C12Q1/68 , C12R1/91
CPC分类号: C07K16/40 , C12N9/12 , C12N9/1205 , A01K2217/05 , A61K48/00 , C12N2799/027
摘要: The present invention relates to AUR-1 and/or AUR-2 polypeptides, nucleic acids encoding such polypeptides, cells, tissues and animals containing such nucleic acids, antibodies to such polypeptides, assays utilizing such polypeptides, and methods relating to all of the foregoing. Methods for treatment, diagnosis, and screening are provided for AUR-1 and/or AUR-2 related diseases or conditions characterized by an abnormal interaction between a AUR-1 and/or AUR-2 polypeptide and a AUR-1 and/or AUR-2 binding partner.
-
33.
公开(公告)号:US20070072261A1
公开(公告)日:2007-03-29
申请号:US10725330
申请日:2003-12-02
申请人: Gregory Plowman , Ricardo Martinez , David Whyte
发明人: Gregory Plowman , Ricardo Martinez , David Whyte
CPC分类号: C12N9/1205 , A61K38/00
摘要: The present invention relates to the nucleic acid molecules encoding an STE20-related family of novel protein kinases, ZC1, ZC2, ZC3, ZC4, STLK2, STLK3, STLK4, STLK5, STLK6, STLK7, KHS2, SULU1, SULU3, GEK2, PAK4 and PAK5, segments and domains thereof, as well as various methods useful for the diagnosis and treatment of various kinase-related diseases and conditions. Mammalian nucleic acid molecules encoding these kinases are particularly disclosed, and more specifically human sources of these nucleic acids are disclosed.
摘要翻译: 本发明涉及编码STE20相关家族新型蛋白激酶ZC1,ZC2,ZC3,ZC4,STLK2,STLK3,STLK4,STLK5,STLK6,STLK7,KHS2,SULU1,SULU3,GEK2,PAK4的核酸分子和 PAK5,其片段和结构域,以及可用于诊断和治疗各种激酶相关疾病和病症的各种方法。 特别公开了编码这些激酶的哺乳动物核酸分子,更具体地公开了这些核酸的人源。
-
公开(公告)号:US20060216730A1
公开(公告)日:2006-09-28
申请号:US11320072
申请日:2005-12-29
申请人: Gregory Plowman , David Whyte , Gerard Manning , Sucha Sudarsanam , Ricardo Martinez , Peter Flanagan , Douglas Clary
发明人: Gregory Plowman , David Whyte , Gerard Manning , Sucha Sudarsanam , Ricardo Martinez , Peter Flanagan , Douglas Clary
CPC分类号: G01N33/6896 , C12Q1/485 , G01N33/57407 , G01N33/6893
摘要: The present invention relates to kinase polypeptides, nucleotide sequences encoding the kinase polypeptides, as well as various products and methods useful for the diagnosis and treatment of various kinase-related diseases and conditions. Through the use of a bioinformatics strategy, mammalian members of the of PTK's and STK's have been identified and their protein structure predicted.
-
公开(公告)号:US20060140954A1
公开(公告)日:2006-06-29
申请号:US11299791
申请日:2005-12-13
CPC分类号: C07K16/40 , C12N9/1205 , C12Q1/485 , G01N2500/00
摘要: The present invention relates to kinase polypeptides, nucleotide sequences encoding the kinase polypeptides, as well as various products and methods useful for the diagnosis and treatment of various kinase-related diseases and conditions. Through the use of a bioinformatics strategy, mammalian members of the PTK's and STK's have been identified and their protein structure predicted.
-
公开(公告)号:US20050142625A1
公开(公告)日:2005-06-30
申请号:US10725121
申请日:2003-12-02
申请人: Gregory Plowman , Ricardo Martinez , David Whyte
发明人: Gregory Plowman , Ricardo Martinez , David Whyte
IPC分类号: C12N15/09 , A61K38/00 , A61K38/55 , A61P9/00 , A61P9/10 , A61P13/12 , A61P25/00 , A61P35/00 , A61P37/00 , C07K16/40 , C12N1/15 , C12N1/19 , C12N1/21 , C12N5/10 , C12N9/12 , C12N15/52 , C12Q1/68 , G01N33/53 , C12N5/06 , G01N33/537 , G01N33/543
CPC分类号: C12N9/1205 , A61K38/00
摘要: The present invention relates to the nucleic acid molecules encoding an STE20-related family of novel protein kinases, ZC1, ZC2, ZC3, ZC4, STLK2, STLK3, STLK4, STLK5, STLK6, STLK7, KHS2, SULU1, SULU3, GEK2, PAK4 and PAK5, segments and domains thereof, as well as various methods useful for the diagnosis and treatment of various kinase-related diseases and conditions. Mammalian nucleic acid molecules encoding these kinases are particularly disclosed, and more specifically human sources of these nucleic acids are disclosed.
摘要翻译: 本发明涉及编码STE20相关家族新型蛋白激酶ZC1,ZC2,ZC3,ZC4,STLK2,STLK3,STLK4,STLK5,STLK6,STLK7,KHS2,SULU1,SULU3,GEK2,PAK4的核酸分子和 PAK5,其片段和结构域,以及可用于诊断和治疗各种激酶相关疾病和病症的各种方法。 特别公开了编码这些激酶的哺乳动物核酸分子,更具体地公开了这些核酸的人源。
-
公开(公告)号:US20050054070A1
公开(公告)日:2005-03-10
申请号:US10716442
申请日:2003-11-20
申请人: Gregory Plowman , David Whyte , Gerard Manning
发明人: Gregory Plowman , David Whyte , Gerard Manning
摘要: The present invention relates to phosphatase polypeptides, nucleotide sequences encoding the phosphatase polypeptides, as well as various products and methods useful for the diagnosis and treatment of various phosphatase-related diseases and conditions. Through the use of a bioinformatics strategy, mammalian members of the MAP kinase phosphatase PTP's and STP's have been identified and their protein structure predicted.
摘要翻译: 本发明涉及磷酸酶多肽,编码磷酸酶多肽的核苷酸序列,以及可用于诊断和治疗各种磷酸酶相关疾病和病症的各种产品和方法。 通过使用生物信息学策略,已经鉴定了MAP激酶磷酸酶PTP和STP的哺乳动物成员,并预测了其蛋白质结构。
-
公开(公告)号:US06495353B1
公开(公告)日:2002-12-17
申请号:US09233857
申请日:1999-01-20
申请人: Gregory Plowman , Peter Flanagan
发明人: Gregory Plowman , Peter Flanagan
IPC分类号: C12N900
CPC分类号: C12N9/1205 , C07K2319/00 , C12Q1/485 , G01N33/574
摘要: The present invention relates in part to hWART nucleic acid molecules. The invention also relates in part to nucleic acid molecules encoding portions of hWART full-length proteins, nucleic acid vectors containing hWART nucleic acid molecules, recombinant cells containing such nucleic acid vectors, polypeptides purified from such recombinant cells, antibodies to such polypeptides, and methods of identifying compounds that modulate the function of an hWART polypeptide. Also disclosed are methods for diagnosing abnormal cell proliferative conditions in an organism using hWART-related molecules or compounds.
摘要翻译: 本发明部分涉及hWART核酸分子。 本发明还部分涉及编码hWART全长蛋白质的部分的核酸分子,含有hWART核酸分子的核酸载体,含有此类核酸载体的重组细胞,从这些重组细胞纯化的多肽,对这些多肽的抗体,以及方法 鉴定调节hWART多肽功能的化合物。 还公开了使用hWART相关分子或化合物诊断生物体中异常细胞增殖状态的方法。
-
公开(公告)号:US20080081688A1
公开(公告)日:2008-04-03
申请号:US11865399
申请日:2007-10-01
申请人: Gregory Plowman
发明人: Gregory Plowman
IPC分类号: A63F13/00
CPC分类号: G07F17/3244 , G07F17/3213 , G07F17/3225 , G07F17/34
摘要: A gaming machine that provides a wagering game, including a user interface in communication with a game controller, through the operation of which a player selects one of a plurality of wager options that determine a number of symbols to be active and inactive in the wagering game. For at least one said wager option at least one, but not all of the plurality of symbols that define a possible said winning combination are rendered inactive for forming the winning combination.
摘要翻译: 一种游戏机,其提供投注游戏,包括与游戏控制器通信的用户界面,所述游戏机通过玩家选择多个下注选项中的一个的操作来确定所述投注游戏中的活跃和不活动的符号数量 。 对于至少一个所述下注选项,定义可能的所述获胜组合的至少一个但不是全部的所述多个符号被赋予无效以形成所述获胜组合。
-
40.
公开(公告)号:US20070269378A1
公开(公告)日:2007-11-22
申请号:US10556440
申请日:2004-06-18
申请人: Gregory Plowman , Felix Karim , Candace Swimmer , Hinrich Habeck , Thomas Koblizek , Stefan Schulte-Merker , Ulrike Eisenmann , Gordon Stott , Torsten Trowe , Andreas Vogel , Joerg Odenthal , Jochen Scheel , Torsten Will , Yinsheng Jin , Lynn Bjerke , Timothy Heuer
发明人: Gregory Plowman , Felix Karim , Candace Swimmer , Hinrich Habeck , Thomas Koblizek , Stefan Schulte-Merker , Ulrike Eisenmann , Gordon Stott , Torsten Trowe , Andreas Vogel , Joerg Odenthal , Jochen Scheel , Torsten Will , Yinsheng Jin , Lynn Bjerke , Timothy Heuer
CPC分类号: G01N33/574 , A01K67/0275 , A01K2217/058 , A01K2227/40 , A01K2267/03 , A61K49/0008 , C12N9/1205 , C12Q1/485 , G01N33/5008 , G01N33/5011 , G01N33/5041
摘要: Human NADK genes are identified as modulators of branching morphogenesis, and thus are therapeutic targets for disorders associated with defective branching morphogenesis function. Methods for identifying modulators of branching morpho-genesis, comprising screening for agents that modulate the activity of NADK are provided.
摘要翻译: 人NADK基因被鉴定为分支形态发生的调节剂,因此是与缺陷支链形态发生功能相关的病症的治疗靶点。 提供用于鉴定分支形态发生的调节剂的方法,包括筛选调节NADK活性的试剂。
-
-
-
-
-
-
-
-
-